189 related articles for article (PubMed ID: 32357955)
1. The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers.
Srivastava S; Wagner PD
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2401-2410. PubMed ID: 32357955
[TBL] [Abstract][Full Text] [Related]
2. Adding Rigor to Biomarker Evaluations-EDRN Experience.
Feng Z; Pepe MS
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2575-2582. PubMed ID: 33172885
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN.
Liu Y; Kaur S; Huang Y; Fahrmann JF; Rinaudo JA; Hanash SM; Batra SK; Singhi AD; Brand RE; Maitra A; Haab BB
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2513-2523. PubMed ID: 32532830
[TBL] [Abstract][Full Text] [Related]
4. The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.
Kammer MN; Deppen SA; Antic S; Jamshedur Rahman SM; Eisenberg R; Maldonado F; Aldrich MC; Sandler KL; Landman B; Massion PP; Grogan EL
Cancer Biomark; 2022; 33(4):449-465. PubMed ID: 35491773
[TBL] [Abstract][Full Text] [Related]
5. The early detection research network: 10-year outlook.
Srivastava S
Clin Chem; 2013 Jan; 59(1):60-7. PubMed ID: 23160065
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics: biomarkers of early detection.
Crichton DJ; Mattmann CA; Thornquist M; Anton K; Hughes JS
Cancer Biomark; 2010; 9(1-6):511-30. PubMed ID: 22112493
[TBL] [Abstract][Full Text] [Related]
7. Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network.
Pass HI; Alimi M; Carbone M; Yang H; Goparaju CM
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2524-2540. PubMed ID: 32699075
[TBL] [Abstract][Full Text] [Related]
8. Barrett's Esophagus and Esophageal Adenocarcinoma Biomarkers.
Grady WM; Yu M; Markowitz SD; Chak A
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2486-2494. PubMed ID: 33093162
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical Translation.
Bresalier RS; Grady WM; Markowitz SD; Nielsen HJ; Batra SK; Lampe PD
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2431-2440. PubMed ID: 32299850
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for the Early Detection of Hepatocellular Carcinoma.
Parikh ND; Mehta AS; Singal AG; Block T; Marrero JA; Lok AS
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2495-2503. PubMed ID: 32238405
[TBL] [Abstract][Full Text] [Related]
11. Systematic, evidence-based discovery of biomarkers at the NCI.
Prensner JR; Chinnaiyan AM; Srivastava S
Clin Exp Metastasis; 2012 Oct; 29(7):645-52. PubMed ID: 22868876
[TBL] [Abstract][Full Text] [Related]
12. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls in Cancer Biomarker Discovery and Validation with Emphasis on Circulating Tumor DNA.
Ren AH; Fiala CA; Diamandis EP; Kulasingam V
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2568-2574. PubMed ID: 32277003
[TBL] [Abstract][Full Text] [Related]
14. The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers.
Feng Z; Kagan J; Pepe M; Thornquist M; Ann Rinaudo J; Dahlgren J; Krueger K; Zheng Y; Patriotis C; Huang Y; Sorbara L; Thompson I; Srivastava S
Clin Chem; 2013 Jan; 59(1):68-74. PubMed ID: 23193062
[TBL] [Abstract][Full Text] [Related]
15. Cancer biomarker discovery and development in gastrointestinal cancers: early detection research network-a collaborative approach.
Srivastava S
Gastrointest Cancer Res; 2007; 1(4 Suppl 2):S60-3. PubMed ID: 19360150
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network.
Borges KA; Dai J; Parikh ND; Schwartz M; Nguyen MH; Roberts LR; Befeler AS; Srivastava S; Rinaudo JA; Feng Z; Marrero JA; Reddy KR
Contemp Clin Trials; 2019 Jan; 76():49-54. PubMed ID: 30439517
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for Lung Cancer Screening and Detection.
Ostrin EJ; Sidransky D; Spira A; Hanash SM
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2411-2415. PubMed ID: 33093160
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in cancer screening: a public health perspective.
Srivastava S; Gopal-Srivastava R
J Nutr; 2002 Aug; 132(8 Suppl):2471S-2475S. PubMed ID: 12163714
[TBL] [Abstract][Full Text] [Related]
19. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
[TBL] [Abstract][Full Text] [Related]
20. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
